The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The nature of the independent relationship between polycystic ovary syndrome (PCOS) and type 2 diabetes remains unclear. Few studies have aimed to clarify this relationship independent of obesity in longitudinal population-based cohorts. RESEARCH DESIGN AND METHODS: We used the Australian Longitudinal Study on Women’s Health (ALSWH) (2000–2015) database to estimate nationwide incidence rates and predictors of type 2 diabetes among women aged 18–42 using person-time and survival analysis. RESULTS: Over a follow-up of 1,919 person-years (PYs), 186 women developed type 2 diabetes. The incidence rate was 4.19/1,000 PYs and 1.02/1,000 PYs (P < 0.001) in PCOS and control subjects. On subgroup analyses across healthy-weight, overweight, and obese categories of women, the incidence rates for type 2 diabetes were 3.21, 4.67, and 8.80, whereas incidence rate ratios were 4.68, 3.52, and 2.36 (P < 0.005) in PCOS versus age-matched control subjects. PCOS was one of the most influential predictors for type 2 diabetes in the entire cohort (hazard ratio 3.23, 95% CI 2.07–5.05, P < 0.001) adjusting for BMI, education, area of residence, and family history of type 2 diabetes. CONCLUSIONS: Women with PCOS are at an increased risk of type 2 diabetes, irrespective of age and BMI. The incidence of type 2 diabetes increases substantially with increasing obesity; yet, PCOS adds a greater relative risk in lean women. Based on the overall moderate absolute clinical risk demonstrated here, guideline recommendations suggest type 2 diabetes screening every 1–3 years in all women with PCOS, across BMI categories and age ranges, with frequency influenced by additional type 2 diabetes risk factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
March, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · cited 1×
“Previous studies have been inconclusive about the independent effect of PCOS on type 2 diabetes, with methodological limitations including small sample sizes (8,9,11), use of”
Standards of Medical Care in Diabetes—2007
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s004 · Cited by 1,190
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/er.18.6.774 · Cited by 1,155
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108
Self-citationWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010 · cited 5×
“We support the consensus statements by the Endocrine Society (13), the AEPCOS(14), theAustralianEvidence-Based Guidelines, and the new international PCOS guidelines (19) by demonstrating a moderate absolute clinical risk, and our data align with current population recommendations for screening every 3 years for those…”
BackgroundInfluentialStepto, N. K., Cassar, S., Joham, A. E., Hutchison, S. K., Harrison, C. L., Goldstein, R. F., & Teede, H. J. (2013) · Human Reproduction · doi:10.1093/humrep/des463 · Cited by 747
Self-citationCohort Profile: The Australian Longitudinal Study on Women's Health
Lee, C. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi098 · Cited by 660
The effect of obesity on polycystic ovary syndrome: a systematic review and meta‐analysis
Lim, S. S., Norman, R. J., Davies, M. J., & Moran, L. J. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01053.x · Cited by 539 · cited 1×
“PCOS has a range of metabolic features, including obesity (4), IR (5), gestational diabetes mellitus (6), and type 2 diabetes (7).”
BackgroundSelf-citationGoodman, N. F., Cobin, R. H., Futterweit, W., Glueck, J. S., Legro, R. S., & Carmina, E. (2015) · Endocrine Practice · doi:10.4158/ep15748.dscpt2 · Cited by 359
Teede, H. J., Joham, A. E., Paul, E., Moran, L. J., Loxton, D., Jolley, D., & Lombard, C. (2013) · Obesity · doi:10.1002/oby.20213 · Cited by 351 · cited 1×
“in this cohort (27), and self-reported BMI has been validated with direct anthropometric measurement among the middle-aged ALSWH cohort (28).”
MethodSelf-citationNorman, R. J., Masters, L., Milner, C. R., Wang, J. X., & Davies, M. J. (2001) · Human Reproduction · doi:10.1093/humrep/16.9.1995 · Cited by 341 · cited 16×
“Our current study found a selfreported incidence of type 2 diabetes of ;4/1,000 PYs in women with PCOS (;0.5% per year).”
BackgroundInfluentialSalley, K. E. S., Wickham, E. P., Cheang, K. I., Essah, P. A., Karjane, N. W., & Nestler, J. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1549 · Cited by 336
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes
Gambineri, A., Patton, L., Altieri, P., Pagotto, U., Pizzi, C., Manzoli, L., & Pasquali, R. (2012) · Diabetes · doi:10.2337/db11-1360 · Cited by 225
Rubin, K. H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01354 · Cited by 195
Burton, N. W., Brown, W., & Dobson, A. (2010) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2010.00618.x · Cited by 176
Ollila, M.-M. E., West, S., Keinänen-Kiukaanniemi, S., Jokelainen, J., Auvinen, J., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dew329 · Cited by 165
An Update on The Diabetes Prevention Program
Ratner, R. E. (2006) · Endocrine Practice · doi:10.4158/ep.12.s1.20 · Cited by 162
Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
Boudreaux, M. Y., Talbott, E. O., Kip, K. E., Brooks, M. M., & Witchel, S. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0056-1 · Cited by 153
Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome
Joham, A. E., Ranasinha, S., Zoungas, S., Moran, L., & Teede, H. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2007 · Cited by 147
Self-citationMorgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1690 · Cited by 136
Casarini, L., & Brigante, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2703 · Cited by 65
Self-reported diabetes is a valid outcome in pragmatic clinical trials and observational studies
Jackson, J., DeFor, T. A., Crain, A. L., Kerby, T. J., Strayer, L., Lewis, C. E., Whitlock, E. P., Williams, S. B., Bonds, D. E., Vitolins, M. Z., et al. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.01.013 · Cited by 58
Kakoly, N. S., Earnest, A., Moran, L. J., Teede, H. J., & Joham, A. E. (2017) · BMC Medicine · doi:10.1186/s12916-017-0957-7 · Cited by 38
Self-citationPrediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
Dargham, S. R., Elshewehy, A. M. M., Dakroury, Y., Kilpatrick, E. S., & Atkin, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-21987-6 · Cited by 22
Research works printed but not linked: 1
- Polycystic Australian Alliance, 2011, Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Cited by
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Self-citationOsibogun, O., Ogunmoroti, O., & Michos, E. D. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.010 · Cited by 423
Diabetes: A metabolic and reproductive disorder in women
Thong, E. P., Codner, E., Laven, J. S. E., & Teede, H. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30345-6 · Cited by 242
Self-citationPolycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke
Zhu, T., Cui, J., & Goodarzi, M. O. (2021) · Diabetes · doi:10.2337/db20-0800 · Cited by 226
“However, some studies that did attempt to match for or statistically adjust for BMI reported positive association between PCOS and diabetes (25,31,32).”
ResultInsulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209
Metadata
- Authors
- Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E.
- Affiliations
- Monash University (AU)
- Monash Health (AU)
- Corresponding author
- Joham, Anju E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-01-31
- Volume
- 42
- Issue
- 4
- Pages
- 560-567
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2911538911
- Cited by
- 174
- References
- 32
- Citations by year
- 2026: 11 · 2025: 31 · 2024: 26 · 2023: 36 · 2022: 18 · 2021: 32 · 2020: 13 · 2019: 7
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, obesity, diabetes incidence, lean women, body mass index, diabetes screening, women's health, risk factors
- MeSH terms
- Adolescent, Adult, Australia, Body Weight, Diabetes Mellitus, Type 2, Female, Humans, Longitudinal Studies, Obesity, Polycystic Ovary Syndrome, Risk, Cohort Studies, Body Mass Index, Incidence, Overweight, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.